Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.
- DOI
- 10.1136/bmjopen-2025-106361
- Published
- 2025 Aug 21
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-106361,
title = {Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.},
author = {Gleeson D and Chapman S and McAteer H and Qin A and Gregory J and Pizzato J and Powell K and Sagoo MK and Ye W and Naylor A and Moorhead L and Pink AE and Woolf R and Barker J and Galloway JB and Cro S and K Mahil S and Smith CH},
year = {2025},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-106361},
url = {https://doi.org/10.1136/bmjopen-2025-106361}
}RIS
TY - JOUR TI - Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol. AU - Gleeson D AU - Chapman S AU - McAteer H AU - Qin A AU - Gregory J AU - Pizzato J AU - Powell K AU - Sagoo MK AU - Ye W AU - Naylor A AU - Moorhead L AU - Pink AE AU - Woolf R AU - Barker J AU - Galloway JB AU - Cro S AU - K Mahil S AU - Smith CH PY - 2025 JO - BMJ open DO - 10.1136/bmjopen-2025-106361 UR - https://doi.org/10.1136/bmjopen-2025-106361 ER -
APA
D, G., S, C., H, M., A, Q., J, G., J, P., K, P., MK, S., W, Y., A, N., L, M., AE, P., R, W., J, B., JB, G., S, C., S, K. M., & CH, S. (2025). Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2025-106361
Source records
- pubmed · retrieved 2026-09-25T18:38:47.208Z